Literature DB >> 11684633

Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors.

C Y Xiao1, A Hara, K Yuhki, T Fujino, H Ma, Y Okada, O Takahata, T Yamada, T Murata, S Narumiya, F Ushikubi.   

Abstract

BACKGROUND: Prostaglandin (PG) I(2) and thromboxane (TX) A(2), the most common prostanoids in the cardiovascular system, are produced abundantly during cardiac ischemia/reperfusion (I/R); their roles in I/R injury, however, remain undetermined. We intended to clarify these roles of PGI(2) and TXA(2) using mice lacking the PGI(2) receptor, IP(-/-) mice, or the TXA(2) receptor, TP(-/-) mice. METHODS AND
RESULTS: The left anterior descending coronary artery was occluded for 1 hour and then reperfused for 24 hours. The size of myocardial infarct in IP(-/-) mice was significantly larger than that in wild-type mice, although the size of the area at risk was similar between the 2 groups of mice. In contrast, there was no such difference between TP(-/-) and wild-type mice. To further determine whether PGI(2) and TXA(2) act directly on the cardiac tissue or indirectly through their action on blood constituents, we perfused excised heart according to the Langendorff technique. The isolated heart was then subjected to global ischemia followed by reperfusion. In IP(-/-) mice, developed tension and coronary flow rate during reperfusion were significantly lower and release of creatine kinase was significantly higher than those in wild-type mice. There were no such differences, however, between TP(-/-) and wild-type mice.
CONCLUSIONS: PGI(2), which was produced endogenously during cardiac I/R, exerts a protective effect on cardiomyocytes independent of its effects on platelets and neutrophils. In contrast, TXA(2) has little role in the cardiac I/R injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684633     DOI: 10.1161/hc4301.098058

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  56 in total

1.  Investigation of the effect of the farnesyl protein transferase inhibitor R115777 on isoprenylation and intracellular signalling by the prostacyclin receptor.

Authors:  Sarah J O'Meara; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

2.  Comprehensive biochemical analysis of rare prostacyclin receptor variants: study of association of signaling with coronary artery obstruction.

Authors:  Jeremiah Stitham; Eric Arehart; Larkin Elderon; Scott R Gleim; Karen Douville; Zsolt Kasza; Kristina Fetalvero; Todd MacKenzie; John Robb; Kathleen A Martin; John Hwa
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

3.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms.

Authors:  Rei Shibata; Kaori Sato; David R Pimentel; Yukihiro Takemura; Shinji Kihara; Koji Ohashi; Tohru Funahashi; Noriyuki Ouchi; Kenneth Walsh
Journal:  Nat Med       Date:  2005-09-11       Impact factor: 53.440

Review 4.  Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

Authors:  Tilo Grosser; Susanne Fries; Garret A FitzGerald
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

5.  Cytosolic phospholipase A(2)α protects against ischemia/reperfusion injury in the heart.

Authors:  Risto Kerkelä; Matthieu Boucher; Raihana Zaka; Erhe Gao; David Harris; Jarkko Piuhola; Jianliang Song; Raisa Serpi; Kathleen C Woulfe; Joseph Y Cheung; Eileen O'Leary; Joseph V Bonventre; Thomas Force
Journal:  Clin Transl Sci       Date:  2011-08       Impact factor: 4.689

Review 6.  Prostanoids and NSAIDs in cardiovascular biology and disease.

Authors:  Babettte B Weksler
Journal:  Curr Atheroscler Rep       Date:  2015-07       Impact factor: 5.113

7.  Neuroprotective properties of prostaglandin I2 IP receptor in focal cerebral ischemia.

Authors:  S Saleem; Z A Shah; T Maruyama; S Narumiya; S Doré
Journal:  Neuroscience       Date:  2010-07-14       Impact factor: 3.590

Review 8.  Lipid mediators in immune regulation and resolution.

Authors:  Derek W Gilroy; David Bishop-Bailey
Journal:  Br J Pharmacol       Date:  2019-03-01       Impact factor: 8.739

9.  Arginine (CGC) codon targeting in the human prostacyclin receptor gene (PTGIR) and G-protein coupled receptors (GPCR).

Authors:  Jeremiah Stitham; Eric J Arehart; Scott Gleim; Karen Douville; Todd MacKenzie; John Hwa
Journal:  Gene       Date:  2007-04-01       Impact factor: 3.688

10.  Regulation of the human prostacyclin receptor gene by the cholesterol-responsive SREBP1.

Authors:  Elizebeth C Turner; B Therese Kinsella
Journal:  J Lipid Res       Date:  2012-09-11       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.